Acadia Healthcare Q1 revenue up 11.9% to $616.7M; reaffirms FY2022 guidance

Acadia Healthcare Company, Inc.

2022-Q1 EPS reported $0.67 revenue$616,653,000

Revenue $616.7M (+11.9% YoY); same-facility revenue +8.6% on 6.2% higher revenue per patient day and 2.2% more patient days.
Adjusted EBITDA $135.5M vs $119.5M YoY; net income $60.8M ($0.67 diluted EPS); adjusted EPS also $0.67.
Affirms FY2022 guidance: revenue $2.55-2.60B, Adj. EBITDA $575-610M, adj. EPS $2.85-3.15.
New CEO Chris Hunter notes strong start; added 28 beds in Q1, plans ~300 beds in 2022, six de novo CTCs and JV openings.
Balance sheet: $140.4M cash, net leverage ~2.3x, $440M available on revolver; repaid $10M on credit facility.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.